Diamines & Chemicals grants 3000 stock options under ESOP-2021 plan
Diamines & Chemicals Ltd granted 3000 stock options to employees under its ESOP-2021 plan on August 4, 2026. The options vest after three years and can be exercised for up to five years at a price of either ₹ 10 face value or 50% of the market price. The scheme has a total cap of 2,00,000 options, with 9643 lapsed and 750 previously exercised.

*this image is generated using AI for illustrative purposes only.
The Nomination and Remuneration Committee (NRC) of diamines & chemicals approved the grant of 3000 stock options to eligible employees under the DACL Employee Stock Option Plan 2021 (ESOP-2021). The decision was taken during a meeting held on August 04, 2026, marking the eighth tranche of grants under the scheme. This move aims to align employee interests with long-term shareholder value through equity participation.
Grant Details and Terms
The company disclosed the grant pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR') and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. The ESOP-2021 was originally approved by shareholders on July 20, 2021, in compliance with the SEBI (Share Based Employee Benefits) Regulations, 2014, which were later replaced by the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 ('SEBI SBEBSE'). The plan was subsequently updated by the NRC and the Board on May 11, 2022.
| Parameter | Details |
|---|---|
| Options Granted | 3000 stock options |
| Vesting Period | 100% vests after three years from grant date |
| Exercise Window | Maximum five years from vesting date |
| Exercise Price | Face value (₹ 10) or 50% of previous day's closing market price |
| Share Face Value | ₹ 10 per equity share |
Each option carries the right to apply for and be allotted one equity share of ₹ 10 face value. The exercise price for eligible employees is determined based on their appointment terms, allowing for grants either at the face value of ₹ 10 or at 50% of the market price, defined as the closing price of the previous trading day from the grant date.
Scheme Status and Limits
The total number of options that can be granted under the ESOP Plan is capped at 2,00,000, representing 2% of the total paid-up share capital. Each exercised option converts into one fully paid-up equity share. The current grant of 3000 options falls within this limit.
As per the disclosure, historical activity under the scheme includes the exercise of 750 options, which resulted in money realized of ₹ 7500. Additionally, 9643 options have lapsed. The total number of shares outstanding following these exercises stands at 10,053,392. There have been no variations to the terms of the options, and the newly granted 3000 options are yet to be exercised, meaning they do not currently impact diluted earnings per share.
Historical Stock Returns for Diamines & Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.04% | -3.24% | -10.49% | -1.23% | -38.44% | -54.74% |
How might the upcoming vesting of these 3,000 options in 2029 impact the company's diluted earnings per share and overall equity structure?
Given that 9,643 options have lapsed historically, what retention strategies is Diamines & Chemicals implementing to ensure higher exercise rates for this eighth tranche?
Will the company need to seek further shareholder approval to grant additional options once the remaining balance of the 2,00,000 option cap is exhausted?


































